Building better therapeutic antibodies: the science, progress and problems to solve
Sponsored by 
Sartorius2026-09-30T13:00:002026-09-30T13:00:002026-09-30T14:00:00
As therapeutic antibodies become more complex, where is the field making real progress and which problems are proving hardest to solve? Hear leading experts share their perspectives.
Therapeutic antibodies have advanced modern medicine, but creating successful new therapeutics is far from straightforward. From understanding complex molecular interactions and engineering antibodies with the right properties to evaluating candidates and exploring new therapeutic formats, researchers are tackling difficult scientific questions across discovery and development.
This live expert panel brings together leading researchers from academia and industry to discuss advances in antibody biology, structure and function, engineering and therapeutic development. The panel will explore where the field is making progress, which scientific challenges remain and the opportunities and complexities associated with antibody-based therapeutics, including antibody–drug conjugates.
What will you learn?
- How researchers are improving our ability to design and develop antibodies with the properties needed for therapeutic applications.
- What structural and molecular insights can tell us about antibody recognition, receptor interactions and therapeutic performance.
- Where the fundamental gaps are in our understanding and how they are still limiting antibody discovery and development.
- How approaches such as antibody–drug conjugates are expanding the potential of antibody-based therapeutics.
- What scientific advances could have the greatest impact on the development of the next generation of antibody therapeutics.
Who should watch?
This webinar is relevant to scientists and research professionals working in antibody discovery, engineering, structural biology, immunology and therapeutic development.
It will also be valuable for professionals involved in drug discovery, biologics development and the research and development of antibody-based therapeutics, including antibody–drug conjugates.
Join the conversation
Whether you work in antibody discovery, engineering, structural biology or therapeutic development, this live expert discussion will give you a clearer view of the scientific progress shaping the field – and the questions researchers still need to answer.
Access the free webinar by registering for a membership or logging into your account.
Already a member? Sign in